1. Home
  2. COCP vs SONM Comparison

COCP vs SONM Comparison

Compare COCP & SONM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • SONM
  • Stock Information
  • Founded
  • COCP 2006
  • SONM 1999
  • Country
  • COCP United States
  • SONM United States
  • Employees
  • COCP N/A
  • SONM N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • SONM Telecommunications Equipment
  • Sector
  • COCP Health Care
  • SONM Telecommunications
  • Exchange
  • COCP Nasdaq
  • SONM Nasdaq
  • Market Cap
  • COCP 15.7M
  • SONM 12.6M
  • IPO Year
  • COCP N/A
  • SONM 2019
  • Fundamental
  • Price
  • COCP $1.80
  • SONM $0.69
  • Analyst Decision
  • COCP Strong Buy
  • SONM
  • Analyst Count
  • COCP 1
  • SONM 0
  • Target Price
  • COCP $6.00
  • SONM N/A
  • AVG Volume (30 Days)
  • COCP 21.6K
  • SONM 12.4M
  • Earning Date
  • COCP 08-13-2025
  • SONM 08-08-2025
  • Dividend Yield
  • COCP N/A
  • SONM N/A
  • EPS Growth
  • COCP N/A
  • SONM N/A
  • EPS
  • COCP N/A
  • SONM N/A
  • Revenue
  • COCP N/A
  • SONM $58,243,000.00
  • Revenue This Year
  • COCP N/A
  • SONM $127.68
  • Revenue Next Year
  • COCP N/A
  • SONM N/A
  • P/E Ratio
  • COCP N/A
  • SONM N/A
  • Revenue Growth
  • COCP N/A
  • SONM N/A
  • 52 Week Low
  • COCP $1.12
  • SONM $0.60
  • 52 Week High
  • COCP $3.26
  • SONM $6.38
  • Technical
  • Relative Strength Index (RSI)
  • COCP 69.71
  • SONM 40.13
  • Support Level
  • COCP $1.46
  • SONM $0.60
  • Resistance Level
  • COCP $1.60
  • SONM $0.74
  • Average True Range (ATR)
  • COCP 0.08
  • SONM 0.21
  • MACD
  • COCP 0.02
  • SONM -0.05
  • Stochastic Oscillator
  • COCP 92.31
  • SONM 6.30

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

Share on Social Networks: